Stevanato Group Reports 8% Revenue Growth in Fiscal Q3 2026
Stevanato Group announced its third-quarter 2026 financial results, reporting 8% revenue growth.
Story updates
11:30:47 AM UTC
SquawkNews
Q3 2026 revenue rose 8% to €326.1M, with organic growth of 8% versus the prior-year period. Net profit rose 16% to €41.8M; the company maintained 2026 guidance and expects lower GLP-1 revenue to temporarily moderate 2027 growth.Material DetailsContext by AI AnalystThe results show continued growth…
11:31:03 AM UTC
SquawkNews
The Company Maintains Fiscal Year 2026 Guidance PIOMBINO DESE, Italy--(BUSINESS WIRE)-- Stevanato Gr
11:31:46 AM UTC
SquawkNews
Stevanato Group 3Q Rev EUR326.1M >STVN
11:40:02 AM UTC
SquawkNews
Stevanato Group: Nettogewinn steigt im dritten Quartal 2026 um 16 Prozent auf 41.8 Millionen Euro; U
Stevanato Group S.p.A. (NYSE:STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the third quarter of 2026.Third Quarter of 2026 Highlights (compar…